nodes	percent_of_prediction	percent_of_DWPC	metapath
Halothane—GABRQ—attention deficit hyperactivity disorder	0.71	1	CbGaD
Halothane—Isoflurane—GABRQ—attention deficit hyperactivity disorder	0.00561	1	CrCbGaD
Halothane—KCNJ6—forebrain—attention deficit hyperactivity disorder	0.00304	0.0259	CbGeAlD
Halothane—KCNJ3—forebrain—attention deficit hyperactivity disorder	0.00251	0.0214	CbGeAlD
Halothane—KCNJ3—cardiovascular system—attention deficit hyperactivity disorder	0.00212	0.0181	CbGeAlD
Halothane—GNG2—forebrain—attention deficit hyperactivity disorder	0.0021	0.0178	CbGeAlD
Halothane—KCNJ6—midbrain—attention deficit hyperactivity disorder	0.00201	0.0171	CbGeAlD
Halothane—RHO—nervous system—attention deficit hyperactivity disorder	0.00177	0.015	CbGeAlD
Halothane—RHO—central nervous system—attention deficit hyperactivity disorder	0.0017	0.0145	CbGeAlD
Halothane—KCNJ3—midbrain—attention deficit hyperactivity disorder	0.00166	0.0141	CbGeAlD
Halothane—KCNJ6—nervous system—attention deficit hyperactivity disorder	0.00165	0.014	CbGeAlD
Halothane—KCNJ6—central nervous system—attention deficit hyperactivity disorder	0.00159	0.0135	CbGeAlD
Halothane—KCNK9—forebrain—attention deficit hyperactivity disorder	0.00159	0.0135	CbGeAlD
Halothane—KCNK18—nervous system—attention deficit hyperactivity disorder	0.00156	0.0133	CbGeAlD
Halothane—KCNJ6—cerebellum—attention deficit hyperactivity disorder	0.00155	0.0132	CbGeAlD
Halothane—KCNK18—central nervous system—attention deficit hyperactivity disorder	0.0015	0.0128	CbGeAlD
Halothane—GLRA1—nervous system—attention deficit hyperactivity disorder	0.00145	0.0123	CbGeAlD
Halothane—KCNK3—forebrain—attention deficit hyperactivity disorder	0.00144	0.0123	CbGeAlD
Halothane—GLRA1—central nervous system—attention deficit hyperactivity disorder	0.0014	0.0119	CbGeAlD
Halothane—KCNJ3—nervous system—attention deficit hyperactivity disorder	0.00136	0.0116	CbGeAlD
Halothane—RHO—brain—attention deficit hyperactivity disorder	0.00135	0.0115	CbGeAlD
Halothane—GRIN3A—forebrain—attention deficit hyperactivity disorder	0.00132	0.0112	CbGeAlD
Halothane—KCNJ3—central nervous system—attention deficit hyperactivity disorder	0.00131	0.0112	CbGeAlD
Halothane—GABRQ—forebrain—attention deficit hyperactivity disorder	0.00129	0.0109	CbGeAlD
Halothane—KCNJ3—cerebellum—attention deficit hyperactivity disorder	0.00128	0.0109	CbGeAlD
Halothane—KCNJ6—brain—attention deficit hyperactivity disorder	0.00126	0.0107	CbGeAlD
Halothane—GLRB—forebrain—attention deficit hyperactivity disorder	0.00125	0.0106	CbGeAlD
Halothane—KCNK3—cardiovascular system—attention deficit hyperactivity disorder	0.00122	0.0104	CbGeAlD
Halothane—GNG2—nervous system—attention deficit hyperactivity disorder	0.00114	0.00967	CbGeAlD
Halothane—GNG2—central nervous system—attention deficit hyperactivity disorder	0.0011	0.00931	CbGeAlD
Halothane—GNG2—cerebellum—attention deficit hyperactivity disorder	0.00107	0.0091	CbGeAlD
Halothane—GLRB—cardiovascular system—attention deficit hyperactivity disorder	0.00106	0.00899	CbGeAlD
Halothane—GRIN2A—forebrain—attention deficit hyperactivity disorder	0.00104	0.00887	CbGeAlD
Halothane—KCNJ3—brain—attention deficit hyperactivity disorder	0.00104	0.00886	CbGeAlD
Halothane—ND1—forebrain—attention deficit hyperactivity disorder	0.001	0.0085	CbGeAlD
Halothane—GABRD—forebrain—attention deficit hyperactivity disorder	0.000932	0.00793	CbGeAlD
Halothane—KCNN4—cardiovascular system—attention deficit hyperactivity disorder	0.000899	0.00765	CbGeAlD
Halothane—GABRG1—forebrain—attention deficit hyperactivity disorder	0.000897	0.00763	CbGeAlD
Halothane—GNG2—brain—attention deficit hyperactivity disorder	0.00087	0.00739	CbGeAlD
Halothane—KCNK10—nervous system—attention deficit hyperactivity disorder	0.000868	0.00738	CbGeAlD
Halothane—GABRA5—forebrain—attention deficit hyperactivity disorder	0.000866	0.00736	CbGeAlD
Halothane—KCNK9—nervous system—attention deficit hyperactivity disorder	0.000862	0.00733	CbGeAlD
Halothane—ND1—cardiovascular system—attention deficit hyperactivity disorder	0.000845	0.00719	CbGeAlD
Halothane—KCNK10—central nervous system—attention deficit hyperactivity disorder	0.000835	0.0071	CbGeAlD
Halothane—KCNK9—central nervous system—attention deficit hyperactivity disorder	0.00083	0.00706	CbGeAlD
Halothane—GLRB—midbrain—attention deficit hyperactivity disorder	0.000826	0.00702	CbGeAlD
Halothane—KCNK10—cerebellum—attention deficit hyperactivity disorder	0.000816	0.00694	CbGeAlD
Halothane—KCNMA1—forebrain—attention deficit hyperactivity disorder	0.000813	0.00691	CbGeAlD
Halothane—KCNK9—cerebellum—attention deficit hyperactivity disorder	0.000811	0.0069	CbGeAlD
Halothane—ATP5D—forebrain—attention deficit hyperactivity disorder	0.000806	0.00685	CbGeAlD
Halothane—ATP2C1—forebrain—attention deficit hyperactivity disorder	0.000795	0.00676	CbGeAlD
Halothane—GABRA4—forebrain—attention deficit hyperactivity disorder	0.000785	0.00668	CbGeAlD
Halothane—KCNK3—nervous system—attention deficit hyperactivity disorder	0.000783	0.00666	CbGeAlD
Halothane—KCNK3—central nervous system—attention deficit hyperactivity disorder	0.000754	0.00641	CbGeAlD
Halothane—GRIN3A—nervous system—attention deficit hyperactivity disorder	0.000716	0.00609	CbGeAlD
Halothane—GABRQ—nervous system—attention deficit hyperactivity disorder	0.000698	0.00593	CbGeAlD
Halothane—GRIN3A—central nervous system—attention deficit hyperactivity disorder	0.000689	0.00586	CbGeAlD
Halothane—GRIN2A—midbrain—attention deficit hyperactivity disorder	0.000689	0.00586	CbGeAlD
Halothane—KCNMA1—cardiovascular system—attention deficit hyperactivity disorder	0.000688	0.00585	CbGeAlD
Halothane—ATP5D—cardiovascular system—attention deficit hyperactivity disorder	0.000681	0.00579	CbGeAlD
Halothane—GLRB—nervous system—attention deficit hyperactivity disorder	0.000679	0.00577	CbGeAlD
Halothane—ATP2C1—cardiovascular system—attention deficit hyperactivity disorder	0.000672	0.00572	CbGeAlD
Halothane—GABRQ—central nervous system—attention deficit hyperactivity disorder	0.000672	0.00571	CbGeAlD
Halothane—KCNK10—brain—attention deficit hyperactivity disorder	0.000663	0.00564	CbGeAlD
Halothane—KCNK9—brain—attention deficit hyperactivity disorder	0.000659	0.0056	CbGeAlD
Halothane—GABRG2—forebrain—attention deficit hyperactivity disorder	0.000657	0.00559	CbGeAlD
Halothane—GABRB2—forebrain—attention deficit hyperactivity disorder	0.000657	0.00559	CbGeAlD
Halothane—GLRB—central nervous system—attention deficit hyperactivity disorder	0.000654	0.00556	CbGeAlD
Halothane—GLRB—cerebellum—attention deficit hyperactivity disorder	0.000639	0.00543	CbGeAlD
Halothane—KCNK2—brain—attention deficit hyperactivity disorder	0.00062	0.00527	CbGeAlD
Halothane—GABRD—midbrain—attention deficit hyperactivity disorder	0.000616	0.00524	CbGeAlD
Halothane—GABRG3—nervous system—attention deficit hyperactivity disorder	0.000611	0.0052	CbGeAlD
Halothane—GABRA2—forebrain—attention deficit hyperactivity disorder	0.0006	0.0051	CbGeAlD
Halothane—KCNK3—brain—attention deficit hyperactivity disorder	0.000598	0.00509	CbGeAlD
Halothane—GABRG1—midbrain—attention deficit hyperactivity disorder	0.000593	0.00504	CbGeAlD
Halothane—GABRG3—central nervous system—attention deficit hyperactivity disorder	0.000588	0.005	CbGeAlD
Halothane—GABRA1—forebrain—attention deficit hyperactivity disorder	0.00058	0.00493	CbGeAlD
Halothane—GABRB1—midbrain—attention deficit hyperactivity disorder	0.000575	0.00489	CbGeAlD
Halothane—GRIN2A—nervous system—attention deficit hyperactivity disorder	0.000566	0.00481	CbGeAlD
Halothane—GRIN3A—brain—attention deficit hyperactivity disorder	0.000547	0.00465	CbGeAlD
Halothane—GRIN2A—central nervous system—attention deficit hyperactivity disorder	0.000545	0.00463	CbGeAlD
Halothane—ND1—nervous system—attention deficit hyperactivity disorder	0.000543	0.00461	CbGeAlD
Halothane—KCNMA1—midbrain—attention deficit hyperactivity disorder	0.000537	0.00457	CbGeAlD
Halothane—GABRQ—brain—attention deficit hyperactivity disorder	0.000533	0.00454	CbGeAlD
Halothane—GRIN2A—cerebellum—attention deficit hyperactivity disorder	0.000533	0.00453	CbGeAlD
Halothane—ATP5D—midbrain—attention deficit hyperactivity disorder	0.000532	0.00452	CbGeAlD
Halothane—ATP2C1—midbrain—attention deficit hyperactivity disorder	0.000525	0.00447	CbGeAlD
Halothane—ND1—central nervous system—attention deficit hyperactivity disorder	0.000522	0.00444	CbGeAlD
Halothane—GLRB—brain—attention deficit hyperactivity disorder	0.000519	0.00441	CbGeAlD
Halothane—GABRD—nervous system—attention deficit hyperactivity disorder	0.000506	0.0043	CbGeAlD
Halothane—GABRB3—forebrain—attention deficit hyperactivity disorder	0.000504	0.00429	CbGeAlD
Halothane—GABRD—central nervous system—attention deficit hyperactivity disorder	0.000487	0.00414	CbGeAlD
Halothane—GABRG1—nervous system—attention deficit hyperactivity disorder	0.000487	0.00414	CbGeAlD
Halothane—GABRA6—nervous system—attention deficit hyperactivity disorder	0.000484	0.00412	CbGeAlD
Halothane—GABRD—cerebellum—attention deficit hyperactivity disorder	0.000476	0.00405	CbGeAlD
Halothane—GABRB1—nervous system—attention deficit hyperactivity disorder	0.000472	0.00402	CbGeAlD
Halothane—GABRA5—nervous system—attention deficit hyperactivity disorder	0.00047	0.004	CbGeAlD
Halothane—GABRG1—central nervous system—attention deficit hyperactivity disorder	0.000469	0.00399	CbGeAlD
Halothane—GABRG3—brain—attention deficit hyperactivity disorder	0.000467	0.00397	CbGeAlD
Halothane—GABRA6—central nervous system—attention deficit hyperactivity disorder	0.000466	0.00397	CbGeAlD
Halothane—GABRG1—cerebellum—attention deficit hyperactivity disorder	0.000458	0.0039	CbGeAlD
Halothane—GABRA6—cerebellum—attention deficit hyperactivity disorder	0.000456	0.00388	CbGeAlD
Halothane—GABRB1—central nervous system—attention deficit hyperactivity disorder	0.000455	0.00387	CbGeAlD
Halothane—GABRA5—central nervous system—attention deficit hyperactivity disorder	0.000452	0.00385	CbGeAlD
Halothane—GABRB1—cerebellum—attention deficit hyperactivity disorder	0.000445	0.00378	CbGeAlD
Halothane—KCNMA1—nervous system—attention deficit hyperactivity disorder	0.000441	0.00375	CbGeAlD
Halothane—KCNN4—brain—attention deficit hyperactivity disorder	0.000441	0.00375	CbGeAlD
Halothane—GABRA3—nervous system—attention deficit hyperactivity disorder	0.000437	0.00372	CbGeAlD
Halothane—ATP5D—nervous system—attention deficit hyperactivity disorder	0.000437	0.00372	CbGeAlD
Halothane—GABRG2—midbrain—attention deficit hyperactivity disorder	0.000434	0.00369	CbGeAlD
Halothane—GABRB2—midbrain—attention deficit hyperactivity disorder	0.000434	0.00369	CbGeAlD
Halothane—GRIN2A—brain—attention deficit hyperactivity disorder	0.000433	0.00368	CbGeAlD
Halothane—ATP2C1—nervous system—attention deficit hyperactivity disorder	0.000432	0.00367	CbGeAlD
Halothane—GABRA4—nervous system—attention deficit hyperactivity disorder	0.000426	0.00362	CbGeAlD
Halothane—KCNMA1—central nervous system—attention deficit hyperactivity disorder	0.000425	0.00361	CbGeAlD
Halothane—GABRA3—central nervous system—attention deficit hyperactivity disorder	0.000421	0.00358	CbGeAlD
Halothane—ATP5D—central nervous system—attention deficit hyperactivity disorder	0.000421	0.00358	CbGeAlD
Halothane—ATP2C1—central nervous system—attention deficit hyperactivity disorder	0.000416	0.00353	CbGeAlD
Halothane—KCNMA1—cerebellum—attention deficit hyperactivity disorder	0.000415	0.00353	CbGeAlD
Halothane—ND1—brain—attention deficit hyperactivity disorder	0.000415	0.00353	CbGeAlD
Halothane—ATP5D—cerebellum—attention deficit hyperactivity disorder	0.000412	0.0035	CbGeAlD
Halothane—GABRA4—central nervous system—attention deficit hyperactivity disorder	0.00041	0.00349	CbGeAlD
Halothane—ATP2C1—cerebellum—attention deficit hyperactivity disorder	0.000406	0.00345	CbGeAlD
Halothane—GABRA4—cerebellum—attention deficit hyperactivity disorder	0.000401	0.00341	CbGeAlD
Halothane—GABRD—brain—attention deficit hyperactivity disorder	0.000387	0.00329	CbGeAlD
Halothane—GABRA1—midbrain—attention deficit hyperactivity disorder	0.000383	0.00326	CbGeAlD
Halothane—GABRG1—brain—attention deficit hyperactivity disorder	0.000372	0.00317	CbGeAlD
Halothane—GABRA6—brain—attention deficit hyperactivity disorder	0.00037	0.00315	CbGeAlD
Halothane—GABRB1—brain—attention deficit hyperactivity disorder	0.000361	0.00307	CbGeAlD
Halothane—GABRA5—brain—attention deficit hyperactivity disorder	0.000359	0.00305	CbGeAlD
Halothane—GABRG2—nervous system—attention deficit hyperactivity disorder	0.000357	0.00303	CbGeAlD
Halothane—GABRB2—nervous system—attention deficit hyperactivity disorder	0.000357	0.00303	CbGeAlD
Halothane—CYP2A6—cerebellum—attention deficit hyperactivity disorder	0.000347	0.00295	CbGeAlD
Halothane—GABRB2—central nervous system—attention deficit hyperactivity disorder	0.000343	0.00292	CbGeAlD
Halothane—GABRG2—central nervous system—attention deficit hyperactivity disorder	0.000343	0.00292	CbGeAlD
Halothane—KCNMA1—brain—attention deficit hyperactivity disorder	0.000337	0.00287	CbGeAlD
Halothane—GABRG2—cerebellum—attention deficit hyperactivity disorder	0.000336	0.00285	CbGeAlD
Halothane—GABRB2—cerebellum—attention deficit hyperactivity disorder	0.000336	0.00285	CbGeAlD
Halothane—GABRA3—brain—attention deficit hyperactivity disorder	0.000334	0.00284	CbGeAlD
Halothane—ATP5D—brain—attention deficit hyperactivity disorder	0.000334	0.00284	CbGeAlD
Halothane—GABRB3—midbrain—attention deficit hyperactivity disorder	0.000333	0.00283	CbGeAlD
Halothane—ATP2C1—brain—attention deficit hyperactivity disorder	0.00033	0.00281	CbGeAlD
Halothane—GABRA4—brain—attention deficit hyperactivity disorder	0.000326	0.00277	CbGeAlD
Halothane—GABRA2—nervous system—attention deficit hyperactivity disorder	0.000326	0.00277	CbGeAlD
Halothane—GABRE—nervous system—attention deficit hyperactivity disorder	0.000323	0.00275	CbGeAlD
Halothane—GABRA1—nervous system—attention deficit hyperactivity disorder	0.000315	0.00268	CbGeAlD
Halothane—GABRA2—central nervous system—attention deficit hyperactivity disorder	0.000314	0.00267	CbGeAlD
Halothane—GABRE—central nervous system—attention deficit hyperactivity disorder	0.000311	0.00264	CbGeAlD
Halothane—GABRA2—cerebellum—attention deficit hyperactivity disorder	0.000307	0.00261	CbGeAlD
Halothane—GABRA1—central nervous system—attention deficit hyperactivity disorder	0.000303	0.00258	CbGeAlD
Halothane—GABRA1—cerebellum—attention deficit hyperactivity disorder	0.000296	0.00252	CbGeAlD
Halothane—CYP2B6—cardiovascular system—attention deficit hyperactivity disorder	0.000289	0.00246	CbGeAlD
Halothane—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.000286	0.00244	CbGeAlD
Halothane—CYP2A6—brain—attention deficit hyperactivity disorder	0.000282	0.0024	CbGeAlD
Halothane—GABRB3—nervous system—attention deficit hyperactivity disorder	0.000274	0.00233	CbGeAlD
Halothane—GABRG2—brain—attention deficit hyperactivity disorder	0.000273	0.00232	CbGeAlD
Halothane—GABRB2—brain—attention deficit hyperactivity disorder	0.000273	0.00232	CbGeAlD
Halothane—CYP2E1—cardiovascular system—attention deficit hyperactivity disorder	0.000271	0.00231	CbGeAlD
Halothane—GABRB3—central nervous system—attention deficit hyperactivity disorder	0.000264	0.00224	CbGeAlD
Halothane—GABRB3—cerebellum—attention deficit hyperactivity disorder	0.000258	0.00219	CbGeAlD
Halothane—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000254	0.00216	CbGeAlD
Halothane—GABRA2—brain—attention deficit hyperactivity disorder	0.000249	0.00212	CbGeAlD
Halothane—GABRE—brain—attention deficit hyperactivity disorder	0.000247	0.0021	CbGeAlD
Halothane—GABRA1—brain—attention deficit hyperactivity disorder	0.000241	0.00205	CbGeAlD
Halothane—ALB—brain—attention deficit hyperactivity disorder	0.000225	0.00191	CbGeAlD
Halothane—GABRB3—brain—attention deficit hyperactivity disorder	0.000209	0.00178	CbGeAlD
Halothane—CYP2B6—nervous system—attention deficit hyperactivity disorder	0.000186	0.00158	CbGeAlD
Halothane—CYP2B6—central nervous system—attention deficit hyperactivity disorder	0.000179	0.00152	CbGeAlD
Halothane—CYP2E1—nervous system—attention deficit hyperactivity disorder	0.000174	0.00148	CbGeAlD
Halothane—CYP2E1—central nervous system—attention deficit hyperactivity disorder	0.000168	0.00143	CbGeAlD
Halothane—CYP2E1—cerebellum—attention deficit hyperactivity disorder	0.000164	0.00139	CbGeAlD
Halothane—CYP2B6—brain—attention deficit hyperactivity disorder	0.000142	0.00121	CbGeAlD
Halothane—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00014	0.00119	CbGeAlD
Halothane—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.000138	0.00117	CbGeAlD
Halothane—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000135	0.00115	CbGeAlD
Halothane—CYP2E1—brain—attention deficit hyperactivity disorder	0.000133	0.00113	CbGeAlD
Halothane—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000133	0.00113	CbGeAlD
Halothane—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.00013	0.0011	CbGeAlD
Halothane—CYP2D6—brain—attention deficit hyperactivity disorder	0.000105	0.000897	CbGeAlD
Halothane—GABRB2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	5.88e-05	0.000352	CbGpPWpGaD
Halothane—GABRA4—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	5.84e-05	0.00035	CbGpPWpGaD
Halothane—GABRA5—Neuronal System—SNAP25—attention deficit hyperactivity disorder	5.82e-05	0.000349	CbGpPWpGaD
Halothane—GABRA5—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	5.76e-05	0.000345	CbGpPWpGaD
Halothane—GNG2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	5.74e-05	0.000344	CbGpPWpGaD
Halothane—GABRA1—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	5.74e-05	0.000344	CbGpPWpGaD
Halothane—NPSR1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	5.73e-05	0.000343	CbGpPWpGaD
Halothane—GABRA5—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	5.71e-05	0.000342	CbGpPWpGaD
Halothane—GABRA3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	5.71e-05	0.000342	CbGpPWpGaD
Halothane—GNG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	5.69e-05	0.000341	CbGpPWpGaD
Halothane—GABRA3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	5.65e-05	0.000339	CbGpPWpGaD
Halothane—GABRA2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	5.62e-05	0.000336	CbGpPWpGaD
Halothane—GABRA3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	5.61e-05	0.000336	CbGpPWpGaD
Halothane—GABRB3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	5.58e-05	0.000334	CbGpPWpGaD
Halothane—GABRA1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	5.57e-05	0.000334	CbGpPWpGaD
Halothane—GABRA2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	5.55e-05	0.000333	CbGpPWpGaD
Halothane—GABRA1—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	5.54e-05	0.000332	CbGpPWpGaD
Halothane—GABRB3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	5.52e-05	0.000331	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	5.52e-05	0.00033	CbGpPWpGaD
Halothane—GABRA2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	5.52e-05	0.00033	CbGpPWpGaD
Halothane—GABRB3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	5.48e-05	0.000328	CbGpPWpGaD
Halothane—GABRG2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	5.48e-05	0.000328	CbGpPWpGaD
Halothane—GNG2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	5.42e-05	0.000325	CbGpPWpGaD
Halothane—GABRG2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	5.42e-05	0.000325	CbGpPWpGaD
Halothane—GABRG3—Neuronal System—COMT—attention deficit hyperactivity disorder	5.39e-05	0.000323	CbGpPWpGaD
Halothane—GABRG2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	5.38e-05	0.000322	CbGpPWpGaD
Halothane—GABRG3—Neuronal System—MAOA—attention deficit hyperactivity disorder	5.35e-05	0.000321	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	5.34e-05	0.00032	CbGpPWpGaD
Halothane—GABRB2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	5.34e-05	0.00032	CbGpPWpGaD
Halothane—GABRB1—Neuronal System—COMT—attention deficit hyperactivity disorder	5.31e-05	0.000318	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	5.28e-05	0.000316	CbGpPWpGaD
Halothane—GABRB1—Neuronal System—MAOA—attention deficit hyperactivity disorder	5.27e-05	0.000316	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	5.26e-05	0.000315	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	5.25e-05	0.000315	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	5.21e-05	0.000312	CbGpPWpGaD
Halothane—GABRA5—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	5.19e-05	0.000311	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.19e-05	0.000311	CbGpPWpGaD
Halothane—GABRA1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	5.15e-05	0.000309	CbGpPWpGaD
Halothane—GABRA3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	5.09e-05	0.000305	CbGpPWpGaD
Halothane—GNG2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	5.06e-05	0.000303	CbGpPWpGaD
Halothane—KCNMA1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	5.05e-05	0.000302	CbGpPWpGaD
Halothane—GABRA6—Neuronal System—COMT—attention deficit hyperactivity disorder	5.03e-05	0.000301	CbGpPWpGaD
Halothane—GNG2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	5.02e-05	0.0003	CbGpPWpGaD
Halothane—GABRA2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	5.01e-05	0.0003	CbGpPWpGaD
Halothane—GABRA6—Neuronal System—MAOA—attention deficit hyperactivity disorder	4.99e-05	0.000299	CbGpPWpGaD
Halothane—GABRB3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	4.97e-05	0.000298	CbGpPWpGaD
Halothane—GABRA4—Neuronal System—COMT—attention deficit hyperactivity disorder	4.96e-05	0.000297	CbGpPWpGaD
Halothane—GABRA4—Neuronal System—MAOA—attention deficit hyperactivity disorder	4.93e-05	0.000295	CbGpPWpGaD
Halothane—RHO—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	4.89e-05	0.000293	CbGpPWpGaD
Halothane—GABRG2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	4.88e-05	0.000292	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.83e-05	0.000289	CbGpPWpGaD
Halothane—GABRA1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	4.79e-05	0.000287	CbGpPWpGaD
Halothane—ND1—Metabolism—CACNB2—attention deficit hyperactivity disorder	4.74e-05	0.000284	CbGpPWpGaD
Halothane—ND1—Metabolism—TPH2—attention deficit hyperactivity disorder	4.74e-05	0.000284	CbGpPWpGaD
Halothane—ATP5D—Metabolism—TPH2—attention deficit hyperactivity disorder	4.74e-05	0.000284	CbGpPWpGaD
Halothane—ATP5D—Metabolism—CACNB2—attention deficit hyperactivity disorder	4.74e-05	0.000284	CbGpPWpGaD
Halothane—GABRA1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	4.74e-05	0.000284	CbGpPWpGaD
Halothane—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	4.72e-05	0.000283	CbGpPWpGaD
Halothane—GABRA1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	4.7e-05	0.000282	CbGpPWpGaD
Halothane—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	4.68e-05	0.00028	CbGpPWpGaD
Halothane—GABRA1—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	4.68e-05	0.00028	CbGpPWpGaD
Halothane—GNG2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	4.66e-05	0.000279	CbGpPWpGaD
Halothane—ATP5D—Metabolism—DPYD—attention deficit hyperactivity disorder	4.66e-05	0.000279	CbGpPWpGaD
Halothane—ND1—Metabolism—DPYD—attention deficit hyperactivity disorder	4.66e-05	0.000279	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	4.6e-05	0.000276	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	4.55e-05	0.000273	CbGpPWpGaD
Halothane—GABRB2—Neuronal System—COMT—attention deficit hyperactivity disorder	4.54e-05	0.000272	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	4.53e-05	0.000272	CbGpPWpGaD
Halothane—GNG2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	4.52e-05	0.00027	CbGpPWpGaD
Halothane—GABRB2—Neuronal System—MAOA—attention deficit hyperactivity disorder	4.51e-05	0.00027	CbGpPWpGaD
Halothane—CYP2A6—Biological oxidations—COMT—attention deficit hyperactivity disorder	4.5e-05	0.00027	CbGpPWpGaD
Halothane—CYP2A6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	4.47e-05	0.000268	CbGpPWpGaD
Halothane—RHO—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	4.44e-05	0.000266	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.44e-05	0.000266	CbGpPWpGaD
Halothane—GNG2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	4.44e-05	0.000266	CbGpPWpGaD
Halothane—GABRA5—Neuronal System—COMT—attention deficit hyperactivity disorder	4.41e-05	0.000264	CbGpPWpGaD
Halothane—GNG2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.38e-05	0.000263	CbGpPWpGaD
Halothane—GABRA5—Neuronal System—MAOA—attention deficit hyperactivity disorder	4.38e-05	0.000262	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.35e-05	0.000261	CbGpPWpGaD
Halothane—ND1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.33e-05	0.00026	CbGpPWpGaD
Halothane—ATP5D—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.33e-05	0.00026	CbGpPWpGaD
Halothane—GABRA3—Neuronal System—COMT—attention deficit hyperactivity disorder	4.33e-05	0.000259	CbGpPWpGaD
Halothane—GABRA3—Neuronal System—MAOA—attention deficit hyperactivity disorder	4.3e-05	0.000258	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	4.28e-05	0.000256	CbGpPWpGaD
Halothane—GABRA1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	4.27e-05	0.000256	CbGpPWpGaD
Halothane—GABRA2—Neuronal System—COMT—attention deficit hyperactivity disorder	4.26e-05	0.000255	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	4.23e-05	0.000254	CbGpPWpGaD
Halothane—GABRB3—Neuronal System—COMT—attention deficit hyperactivity disorder	4.23e-05	0.000253	CbGpPWpGaD
Halothane—GABRA2—Neuronal System—MAOA—attention deficit hyperactivity disorder	4.23e-05	0.000253	CbGpPWpGaD
Halothane—GABRB3—Neuronal System—MAOA—attention deficit hyperactivity disorder	4.2e-05	0.000251	CbGpPWpGaD
Halothane—GABRG2—Neuronal System—COMT—attention deficit hyperactivity disorder	4.15e-05	0.000249	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	4.14e-05	0.000248	CbGpPWpGaD
Halothane—GABRQ—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	4.14e-05	0.000248	CbGpPWpGaD
Halothane—GABRG2—Neuronal System—MAOA—attention deficit hyperactivity disorder	4.12e-05	0.000247	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	4.1e-05	0.000246	CbGpPWpGaD
Halothane—GNG2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	4.08e-05	0.000245	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	4.07e-05	0.000244	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	4.03e-05	0.000241	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	4.02e-05	0.000241	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.98e-05	0.000238	CbGpPWpGaD
Halothane—ND1—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.79e-05	0.000227	CbGpPWpGaD
Halothane—ATP5D—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.79e-05	0.000227	CbGpPWpGaD
Halothane—ALB—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	3.77e-05	0.000226	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	3.75e-05	0.000224	CbGpPWpGaD
Halothane—GNG2—Metabolism—TPH2—attention deficit hyperactivity disorder	3.74e-05	0.000224	CbGpPWpGaD
Halothane—GNG2—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.74e-05	0.000224	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.71e-05	0.000222	CbGpPWpGaD
Halothane—GNG2—Metabolism—DPYD—attention deficit hyperactivity disorder	3.68e-05	0.000221	CbGpPWpGaD
Halothane—CYP2B6—Biological oxidations—COMT—attention deficit hyperactivity disorder	3.63e-05	0.000218	CbGpPWpGaD
Halothane—GABRA1—Neuronal System—COMT—attention deficit hyperactivity disorder	3.63e-05	0.000217	CbGpPWpGaD
Halothane—CYP2B6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	3.61e-05	0.000216	CbGpPWpGaD
Halothane—ND1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.61e-05	0.000216	CbGpPWpGaD
Halothane—ATP5D—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.61e-05	0.000216	CbGpPWpGaD
Halothane—GABRA1—Neuronal System—MAOA—attention deficit hyperactivity disorder	3.6e-05	0.000216	CbGpPWpGaD
Halothane—ALB—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	3.6e-05	0.000216	CbGpPWpGaD
Halothane—CYP2B6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	3.58e-05	0.000215	CbGpPWpGaD
Halothane—CYP2E1—Biological oxidations—COMT—attention deficit hyperactivity disorder	3.56e-05	0.000213	CbGpPWpGaD
Halothane—CYP2E1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	3.53e-05	0.000212	CbGpPWpGaD
Halothane—CYP2E1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	3.51e-05	0.00021	CbGpPWpGaD
Halothane—GNG2—Signaling by Wnt—EP300—attention deficit hyperactivity disorder	3.49e-05	0.000209	CbGpPWpGaD
Halothane—GNG2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.42e-05	0.000205	CbGpPWpGaD
Halothane—GABRG3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	3.41e-05	0.000204	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.38e-05	0.000203	CbGpPWpGaD
Halothane—GABRB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	3.36e-05	0.000201	CbGpPWpGaD
Halothane—GABRA6—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	3.18e-05	0.00019	CbGpPWpGaD
Halothane—ALB—Platelet activation, signaling and aggregation—ADRA2A—attention deficit hyperactivity disorder	3.14e-05	0.000188	CbGpPWpGaD
Halothane—GABRA4—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	3.14e-05	0.000188	CbGpPWpGaD
Halothane—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	3.09e-05	0.000185	CbGpPWpGaD
Halothane—ALB—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	3.09e-05	0.000185	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.08e-05	0.000184	CbGpPWpGaD
Halothane—GNG2—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.99e-05	0.000179	CbGpPWpGaD
Halothane—ATP5D—Metabolism—COMT—attention deficit hyperactivity disorder	2.87e-05	0.000172	CbGpPWpGaD
Halothane—ND1—Metabolism—COMT—attention deficit hyperactivity disorder	2.87e-05	0.000172	CbGpPWpGaD
Halothane—GABRB2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	2.87e-05	0.000172	CbGpPWpGaD
Halothane—GNG2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.86e-05	0.000171	CbGpPWpGaD
Halothane—ND1—Metabolism—MAOA—attention deficit hyperactivity disorder	2.85e-05	0.000171	CbGpPWpGaD
Halothane—ATP5D—Metabolism—MAOA—attention deficit hyperactivity disorder	2.85e-05	0.000171	CbGpPWpGaD
Halothane—GNG2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.85e-05	0.000171	CbGpPWpGaD
Halothane—GABRA5—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	2.79e-05	0.000167	CbGpPWpGaD
Halothane—GABRA3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	2.74e-05	0.000164	CbGpPWpGaD
Halothane—GABRA2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	2.69e-05	0.000161	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.69e-05	0.000161	CbGpPWpGaD
Halothane—GABRB3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	2.67e-05	0.00016	CbGpPWpGaD
Halothane—GABRG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	2.63e-05	0.000157	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.62e-05	0.000157	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.6e-05	0.000156	CbGpPWpGaD
Halothane—ALB—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	2.58e-05	0.000155	CbGpPWpGaD
Halothane—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	2.53e-05	0.000151	CbGpPWpGaD
Halothane—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	2.51e-05	0.00015	CbGpPWpGaD
Halothane—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	2.5e-05	0.00015	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.5e-05	0.00015	CbGpPWpGaD
Halothane—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	2.49e-05	0.000149	CbGpPWpGaD
Halothane—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	2.49e-05	0.000149	CbGpPWpGaD
Halothane—GABRA1—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	2.48e-05	0.000148	CbGpPWpGaD
Halothane—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	2.47e-05	0.000148	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.42e-05	0.000145	CbGpPWpGaD
Halothane—KCNMA1—Hemostasis—EP300—attention deficit hyperactivity disorder	2.41e-05	0.000145	CbGpPWpGaD
Halothane—GNG2—Hemostasis—EP300—attention deficit hyperactivity disorder	2.4e-05	0.000144	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.38e-05	0.000143	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.35e-05	0.000141	CbGpPWpGaD
Halothane—GABRA1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	2.29e-05	0.000137	CbGpPWpGaD
Halothane—GNG2—Metabolism—COMT—attention deficit hyperactivity disorder	2.27e-05	0.000136	CbGpPWpGaD
Halothane—GNG2—Metabolism—MAOA—attention deficit hyperactivity disorder	2.25e-05	0.000135	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.19e-05	0.000131	CbGpPWpGaD
Halothane—RHO—Disease—EP300—attention deficit hyperactivity disorder	1.98e-05	0.000119	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.84e-05	0.00011	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.79e-05	0.000107	CbGpPWpGaD
Halothane—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	1.65e-05	9.89e-05	CbGpPWpGaD
Halothane—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	1.64e-05	9.82e-05	CbGpPWpGaD
Halothane—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	1.63e-05	9.76e-05	CbGpPWpGaD
Halothane—ALB—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	1.62e-05	9.71e-05	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.53e-05	9.19e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.49e-05	8.9e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.46e-05	8.72e-05	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.39e-05	8.33e-05	CbGpPWpGaD
Halothane—ALB—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	1.31e-05	7.87e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—TPH2—attention deficit hyperactivity disorder	1.27e-05	7.62e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.27e-05	7.62e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.25e-05	7.49e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—DPYD—attention deficit hyperactivity disorder	1.25e-05	7.49e-05	CbGpPWpGaD
Halothane—ATP5D—Metabolism—EP300—attention deficit hyperactivity disorder	1.23e-05	7.38e-05	CbGpPWpGaD
Halothane—ND1—Metabolism—EP300—attention deficit hyperactivity disorder	1.23e-05	7.38e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.16e-05	6.96e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.03e-05	6.19e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—TPH2—attention deficit hyperactivity disorder	1.03e-05	6.14e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.03e-05	6.14e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.02e-05	6.13e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.02e-05	6.09e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—DPYD—attention deficit hyperactivity disorder	1.01e-05	6.04e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—TPH2—attention deficit hyperactivity disorder	1e-05	6.02e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—CACNB2—attention deficit hyperactivity disorder	1e-05	6.02e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—DPYD—attention deficit hyperactivity disorder	9.88e-06	5.92e-05	CbGpPWpGaD
Halothane—GNG2—Metabolism—EP300—attention deficit hyperactivity disorder	9.72e-06	5.82e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.67e-06	5.8e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.38e-06	5.62e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.19e-06	5.5e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.63e-06	5.17e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—TPH2—attention deficit hyperactivity disorder	8.63e-06	5.17e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—DPYD—attention deficit hyperactivity disorder	8.49e-06	5.09e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.2e-06	4.91e-05	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.13e-06	4.87e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.03e-06	4.81e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.9e-06	4.73e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.81e-06	4.68e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—COMT—attention deficit hyperactivity disorder	7.7e-06	4.61e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—MAOA—attention deficit hyperactivity disorder	7.65e-06	4.58e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.65e-06	4.58e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	7.13e-06	4.27e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	7.13e-06	4.27e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	7.07e-06	4.23e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	7.07e-06	4.23e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	7.01e-06	4.2e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	6.95e-06	4.16e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.9e-06	4.13e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	6.75e-06	4.04e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.57e-06	3.94e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	6.52e-06	3.91e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	6.46e-06	3.87e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—COMT—attention deficit hyperactivity disorder	6.21e-06	3.72e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—MAOA—attention deficit hyperactivity disorder	6.17e-06	3.7e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—COMT—attention deficit hyperactivity disorder	6.09e-06	3.65e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—MAOA—attention deficit hyperactivity disorder	6.04e-06	3.62e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	5.7e-06	3.41e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	5.65e-06	3.38e-05	CbGpPWpGaD
Halothane—ALB—Hemostasis—EP300—attention deficit hyperactivity disorder	5.53e-06	3.31e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.43e-06	3.25e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.38e-06	3.22e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—COMT—attention deficit hyperactivity disorder	5.23e-06	3.13e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—MAOA—attention deficit hyperactivity disorder	5.19e-06	3.11e-05	CbGpPWpGaD
Halothane—ALB—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	5.04e-06	3.02e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	4.66e-06	2.79e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	4.66e-06	2.79e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	4.59e-06	2.75e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	4.32e-06	2.59e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	4.29e-06	2.57e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	4.28e-06	2.56e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.26e-06	2.55e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	4.25e-06	2.55e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	4.12e-06	2.47e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.73e-06	2.23e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.55e-06	2.12e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—EP300—attention deficit hyperactivity disorder	3.3e-06	1.98e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	2.82e-06	1.69e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	2.8e-06	1.68e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—EP300—attention deficit hyperactivity disorder	2.66e-06	1.6e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—EP300—attention deficit hyperactivity disorder	2.61e-06	1.56e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—EP300—attention deficit hyperactivity disorder	2.24e-06	1.34e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	1.85e-06	1.11e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	1.84e-06	1.1e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	1.21e-06	7.25e-06	CbGpPWpGaD
